Physician profile

Aaron Raney

Surgery · Meridian, ID

NPI 1356889455

$451.72

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$50.09

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Becton, Dickinson and Company $147.58 2022
Haemonetics Corporation $98.36 2022
Smith+Nephew, INC. $81.88 2022
Csl Behring $27.75 2022
Intuitive Surgical, INC. $23.63 2022
Medtronic, INC. $22.43 2021
Braintree Laboratories, INC. $17.75 2024 Suflave
Merck Sharp & Dohme LLC $17.36 2024 Bridion
Baxter Healthcare $14.98 2023 Floseal

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Aaron Raney

$451.72

in general payments reported 2019-2025

Years
2021-2024
Top company
Becton, Dickinson and Company

https://glasscript.com/doctor/4227045/aaron-raney

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.